Hives Clinical Research Studies

Hives, or urticaria are itchy red or skin-colored welts that can appear on the skin of people of all ages. These can be caused by numerous things such as an allergic reaction to a food or drug, however, experts are unsure of the exact cause of hives and urticaria. We are currently conducting a clinical research study investigating a new type of oral medication for the treatment of urticaria. Medication will be provided at no cost with no insurance needed for those who qualify, you will be reimbursed for your time and travel, and will receive care from physicians affiliated with the Clinical Research Center of Alabama.

For more information on any of the following hives clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing [email protected]

Investigational biologic infusion study

Age 19-75


The main purpose of this study is to evaluate the effectiveness and safety profile of CDX-0159 in patients with chronic urticaria who remain symptomatic despite treatment with antihistamines.


Age 19-<80


This study is being done to learn more about the study drug tezepelumab in people with CSU. The study will see how effective tezepelumab is in improving itching and the number of hives experienced, in addition to if other symptoms of CSU improve while on study treatment. The study will also see if there are any side effects from the study drug and what doses of tezepelumab are safe for people to take. It will evaluate the effect of tezepelumab by assessing how bad your itch and hive count is while you are on study treatment and if there have been any improvements.

Become a Participant in our Hives Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.